NCT07322354 (RECHARJME-RCT) is a NA clinical trial of Recharjme Multi-Modal Rest Cabin in Employee Well-being, sponsored by Laval University.

Who is sponsoring NCT07322354?

NCT07322354 is sponsored by Laval University.

What drugs are being tested in NCT07322354?

Interventions in NCT07322354: Recharjme Multi-Modal Rest Cabin.

What condition does NCT07322354 study?

NCT07322354 studies Employee Well-being, Work-related Outcomes.

Is NCT07322354 still recruiting?

NCT07322354 is currently completed. Last updated 8 January 2026.

Last reviewed 2026-01-08 · How we verify

NCT07322354: RECHARJME-RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Multi-Modal Workplace Rest Cabin on Worker Well-Being

Completed NA Last updated 8 January 2026

What this trial tests

NA trial testing Recharjme Multi-Modal Rest Cabin in Employee Well-being in 82 participants. Completed in 10 April 2025.

Timeline

1 May 2024

Primary endpoint
10 April 2025

10 April 2025

Quick facts

Lead sponsor	Laval University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	82
Start date	1 May 2024
Primary completion	10 April 2025
Estimated completion	10 April 2025
Sites	4 locations across Canada

Drugs / interventions tested

Recharjme Multi-Modal Rest Cabin

Conditions studied

Employee Well-being — all drugs for Employee Well-being →
Work-related Outcomes — all drugs for Work-related Outcomes →

Sponsor

Laval University

Who can join

18 and older, any sex, with Employee Well-being or Work-related Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines whether access to a rest cabin in the workplace supports employee well-being. Employees of a Canadian insurance company are randomly assigned to one of two groups: immediate access to the rest cabin or a waiting-list control group that receives access after one month. The rest cabin is installed directly in the workplace and can be reserved for short sessions during the workday. It offers multiple relaxation options, including guided meditation, massage therapy, light therapy, and a zero-gravity chair. Employees choose which options to use during each session. Participants complete questionnaires before group assignment and again one month later. Employees who receive immediate access to the cabin also complete additional follow-up questionnaires at later time points. The study compares changes in general well-being and work-related outcomes between employees who have access to the cabin and those who do not during the initial study period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effects of using a multi-modal rest cabin versus a waitlist control on worker well-being: A pragmatic randomized controlled trial
Pacheco T, Gagnon J, Khau M, Coulombe S. · · 2026 · DOI 10.21203/rs.3.rs-8564851/v1

Verify or expand the search:

Other Laval University trials

Trials by the same sponsor.

NCT07491887 — Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption · NA · not yet recruiting
NCT07366827 — Effectiveness of Motorised Lumbar Support for Non-specific Low Back Pain · NA · not yet recruiting
NCT07317973 — A Study About Patient Decision Aids Designed to Help Parents and Guardians in Canada Make Evidence-informed, Values-cong · NA · not yet recruiting
NCT07293312 — Optimizing the Use of Virtual Reality in Rehabilitation for Individuals With Persistent Shoulder Pain · NA · not yet recruiting
NCT07201870 — Digital Preparation for Bariatric Surgery: Feasability Pilot Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07322354 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laval University
Last refreshed: 8 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07322354.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing